Is It Too Late To Consider Argan (AGX) After Its Surging Share Price?

Argan, Inc.

Argan, Inc.

AGX

0.00

  • If you are wondering whether Argan's share price now reflects its true worth, the recent numbers give you plenty to think about.
  • The stock last closed at US$652.99, with returns of 9.2% over 7 days, 49.3% over 30 days, 100.3% year to date, 333.3% over 1 year and a very large gain over 3 and 5 years.
  • Recent coverage has focused on Argan's position within the construction and capital goods space and how the company is exposed to large infrastructure and engineering projects. This news has helped frame the current share price moves as investors weigh contract pipelines, project execution and sector sentiment.
  • Despite the strong share price history, Argan currently holds a valuation score of 0 out of 6. The next sections will compare different valuation approaches and then finish with a broader way to think about what this score really means for you.

Argan scores just 0/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Argan Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes estimates of a company’s future cash flows and discounts them back to today using a required rate of return. The goal is to translate those projected dollars into a single present value per share.

For Argan, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is about $409.5 million. Analysts provide free cash flow estimates for several years ahead, and Simply Wall St then extrapolates further to build ten year projections, such as a projected free cash flow of $263.4 million in 2035, all in US$ terms.

Aggregating and discounting these projected cash flows results in an estimated intrinsic value of about $279.29 per share. Compared to the recent share price of $652.99, the DCF output suggests the stock is 133.8% above this model’s estimate and therefore screens as overvalued on this measure alone.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Argan may be overvalued by 133.8%. Discover 56 high quality undervalued stocks or create your own screener to find better value opportunities.

AGX Discounted Cash Flow as at Apr 2026
AGX Discounted Cash Flow as at Apr 2026

Approach 2: Argan Price vs Earnings

For a profitable company like Argan, the P/E ratio is a useful way to relate what you pay for each share to the earnings that support that price. Investors usually expect higher P/E ratios when they see stronger growth potential and lower perceived risk, and lower P/E ratios when growth looks more modest or risks are higher.

Argan currently trades on a P/E of 66.10x. That sits above the Construction industry average of 44.19x and also above the peer average of 39.79x, which already suggests the market is placing a relatively high value on each dollar of Argan's earnings compared with many sector names.

Simply Wall St's Fair Ratio for Argan is 39.78x. This is a proprietary estimate of what Argan's P/E "should" be after accounting for factors like its earnings growth profile, industry, profit margins, market cap and company specific risks. Because it blends these variables into one number, the Fair Ratio can be more tailored than a simple comparison with peers or the broader industry.

Set against the current 66.10x P/E, the Fair Ratio of 39.78x points to Argan trading at a richer level than this model would suggest.

Result: OVERVALUED

NYSE:AGX P/E Ratio as at Apr 2026
NYSE:AGX P/E Ratio as at Apr 2026

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Argan Narrative

Earlier there was a reference to an even better way to understand valuation. This is where Narratives come in as a simple way for you to attach a clear story about Argan to concrete numbers like fair value, future revenue, earnings and margins.

A Narrative on Simply Wall St is your own view of the company written out as a story, then tied directly to a forecast and a fair value. This means you are not just looking at ratios; you are deciding what you believe about Argan and seeing what that belief implies for the share price.

These Narratives sit inside the Community page on Simply Wall St, are used by millions of investors, and are designed so you can quickly compare the fair value from your story with the current price. This can help you decide whether Argan looks more like a potential entry, a hold, or something to exit.

Importantly, Narratives update as new information arrives. When Argan reports results like record revenue of US$944.6m, a US$2.9b backlog, or new analyst fair values between about US$375 and US$550, your story and fair value can move with that data instead of staying static.

For example, one Argan Narrative might lean on the lower fair value of US$375 and focus on risks to gas heavy projects and margins. Another might use the higher fair value of US$550 and focus on record backlog, cash of about US$895m and power demand from AI and data centers. Seeing these side by side can help you decide which story, and which fair value, you find more convincing.

Do you think there's more to the story for Argan? Head over to our Community to see what others are saying!

NYSE:AGX 1-Year Stock Price Chart
NYSE:AGX 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.